Publication | Closed Access

Biological evaluation and molecular docking studies of AA3052, a compound containing a μ-selective opioid peptide agonist DALDA and d-Phe-Phe-d-Phe-Leu-Leu-NH2, a substance P analogue

Molecular PharmacologyDrug TargetBiochemistryMedicineMechanism Of ActionPharmacological AgentPeptide SciencePharmacotherapyBiological EvaluationPharmacologyDrug DiscoverySubstance P Analogue